Reversible conduction failure in acute inflammatory demyelinating polyneuropathy [PDF]
Reversible conduction failure (RCF) has been documented in acute motor axonal neuropathy (AMAN) and is considered a sign of nodopathy. Several reports of RCF in acute inflammatory demyelinating polyneuropathy (AIDP) have suggested that it could be a ...
Sooyoung Kim +2 more
doaj +4 more sources
A young adult with leptospirosis associated acute inflammatory demyelinating polyneuropathy [PDF]
Leptospirosis is a zoonotic disease that commonly affects the liver and kidney. It can rarely affect the neurological system with aseptic meningitis being the commonest neurological presentation.
Herman Bagula +2 more
doaj +4 more sources
A study on the role of serum uric acid in differentiating acute inflammatory demyelinating polyneuropathy from acute-onset chronic inflammatory demyelinating polyneuropathy. [PDF]
AbstractBackground and purposeClinical symptoms and laboratory indices for acute inflammatory demyelinating polyneuropathy (AIDP), a variant of Guillain−Barré syndrome, and acute‐onset chronic inflammatory demyelinating polyneuropathy (A‐CIDP) were analyzed to identify factors that could contribute to early differential diagnosis.MethodsA retrospective
Zhang W +5 more
europepmc +4 more sources
Sixteen percent of chronic inflammatory demyelinating polyneuropathy (CIDP) patients may present acutely like acute idiopathic demyelinating polyneuropathy (AIDP) the demyelinating form of GBS, developing in
Malek Mansour +5 more
doaj +2 more sources
Acute Onset Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19
The cases of Guillain Barre Syndrome (GBS) have been reported following the coronavirus disease 2019 (COVID-19). Here, we describe a case that evolved from GBS to chronic inflammatory demyelinating polyneuropathy (CIDP) after COVID-19 in terms of ...
Nilgün Çınar +4 more
doaj +4 more sources
Acute inflammatory demyelinating polyneuropathy (AIDP) and acute‐onset chronic inflammatory demyelinating polyneuropathy (A‐CIDP) are conditions presenting overlapping clinical features during early stages (first 4 weeks), although the latter may progress after 8 weeks.
Luis Querol, Mariano Marrodan
exaly +6 more sources
Early identification of 'acute-onset' chronic inflammatory demyelinating polyneuropathy [PDF]
Distinguishing patients with acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy prior to relapse is often challenging at the onset of their clinical presentation. In the present study, nerve excitability tests were used in conjunction with the clinical phenotype and disease staging, to ...
Jia-Ying Sung, Jowy Tani, Susanna B Park
exaly +3 more sources
Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy. [PDF]
Pembrolizumab is a humanized monoclonal antibody that blocks the programmed cell death 1 (PD-1) pathway, thereby enhancing antitumor immunity. As the use of immune checkpoint inhibitors becomes more prevalent, so do immune-related adverse events associated with their use.
Manam R +6 more
europepmc +4 more sources
Inflammatory demyelinating polyneuropathy after total hip arthroplasty
Inflammatory demyelinating polyneuropathy is a rare but devastating condition. Guillain-Barré syndrome is the most common cause with acute inflammatory demyelinating polyneuropathy being the most common subtype that follows a monophasic course and does ...
Shane R. Hess, DO +3 more
doaj +3 more sources
Acute Inflammatory Demyelinating Polyneuropathy (AIDP) Masked by Autoimmune Thyroiditis [PDF]
Abstract Hashimoto’s thyroiditis and Guillain-Barre syndrome (GBS) are autoimmune disorders that are both well-known in their own right. Hashimoto’s is one of the most common causes of primary hypothyroidism, and GBS involves immune mediated damage to the peripheral nervous system.
Wirtshafter S, Iqbal I.
europepmc +3 more sources

